1[1]Komminoth P, Heitz P, Kloppel G. Pathology of MEN-1:Morphology, clinopathologic correlations and tumor development[J]. IntlJ Med ,1998,243:455-464.
2[2]Soga J, Yakuwa Y. Somatostationma/inhibitory syndrome's statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas[J]. J Exp Clin Cancer Res , 1999,18:13-22.
3[3]Schuppe HC, Neumann NJ, Schock- skasa G, et al. Secondary infertility as early symptom in a man with multiple endocrineneoplasia-type 1[J]. Hum Reprod ,2002, 14: 252-254.
4[4]Darling TN, Skarulis MC, Steiberg SM, et al. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1[J]. Arch Dermatol, 2000, 133: 853-857.
5[5]Gortz B, Roth J, Speel EJ,et al. MEN 1 gene mutation analysis of sporadic adrenocortical lesions[J]. Int J Cancer, 2003,80: 373-379.
6[6]Kato H, Uchimura I, Morohoshi M, et al. Multiple endocrine neoplasia type 1 associated with spinal ependymoma[J]. Intern Med,2000, 35: 285-289.
7[7]Vortmeyer AO, Boni R, Pak E. Multiple endocrine neoplasia 1 gene alterations in MEN 1- associated and sporadic lipomas
8[8]. J Natl Cancer Inst,1998, 90: 398-399.
9[9]Paul Komminoth. Review: Multiple Endocrine Neoplasia Type 1, Sporadic Neuroendocrine Tumors, and MENIN[J]. Molecular Pathology,2002,8(3): 107- 112.
10[10]Larsson C, Shepherd J, Nakamura Y, et al. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms[J]. J Clin Invest,2002,89: 1 344-1 349.
